Alicia & Claudia’s Migraine Journey with Vyepti

For Alicia, migraines weren’t just a clinical diagnosis—they were a part of growing up. Since middle school, she’s navigated the unpredictable terrain of migraine attacks, a condition that runs deep in her family. Her mom, Claudia, and brother also suffer from them, making migraines a shared, if unwelcome, thread in their lives.

Initially, Alicia managed her symptoms with Excedrin and triptans, but as she entered adulthood, her migraines became more frequent and severe. She explored newer options—injectables like Emgality and Ajovy—but experienced localized reactions. Oral therapies like Ubrelvy and Qulipta either caused side effects or fell short of relief. After a particularly intense migraine landed her in urgent care, Alicia knew it was time for a change.

As a nurse practitioner at Sage Infusion, Alicia had already seen firsthand how Vyepti was transforming the lives of her patients. Encouraged by their success and guided by her neurologist, she decided to try Vyepti herself. After just one dose, Alicia noticed a remarkable shift: her migraines became more manageable, and even her known triggers—strong fragrances, dehydration, long hours at the computer, and yes, even the occasional glass of wine—no longer led to severe episodes.

But Alicia’s story doesn’t end there—it beautifully intersects with her mother’s.

Claudia has battled migraines for over 40 years. Her episodes were debilitating, often lasting days and accompanied by severe nausea and vomiting. She missed countless workdays and had multiple ER visits. Despite trying “everything under the sun”—from daily preventatives like amitriptyline and topamax to injectables like Emgality and Aimovig—Claudia struggled to find a treatment she could tolerate.

It was Alicia who introduced her mom to Vyepti, sharing the positive feedback she’d heard from patients and her own early success. Claudia brought the idea to her neurologist, and with Sage Infusion’s help—especially in securing financial assistance—she was able to begin treatment quickly and affordably.

Now three doses in, Claudia is experiencing a level of relief she hadn’t thought possible. Her migraines are significantly less intense, shorter in duration, and easily managed with rescue medications. For the first time in decades, she feels like she’s reclaiming her life from the grip of chronic pain.

At Sage Infusion, Alicia and Claudia aren’t just patients—they’re part of a story that reflects hope, resilience, and the power of personalized care. Their journey reminds us that healing can be both clinical and deeply personal, and that sometimes, the best medicine is found not just in science, but in shared experience.

Vyepti (eptinezumab-jjmr) is an FDA-approved intravenous therapy designed to prevent migraines in adults. It works by targeting CGRP, a protein involved in migraine attacks, and is administered as a 30-minute infusion once every three months. Its convenient dosing schedule and rapid onset of action make it a valuable option for patients seeking consistent, long-term relief from chronic or episodic migraines.

If you or a loved one struggles with migraines, ask your doctor if Vyepti might be right for you—and reach out to Sage Infusion to learn how to get started today. Our team is here to support your journey toward better days and fewer migraines.